Matches in Nanopublications for { ?s ?p "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 27 of
27
with 100 items per page.
- NP510926.RAOwPpeKicAzrdMVfLrXF5z1Mp3k8qQ4SeNFIaEzfZ_uE130_assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP510926.RAOwPpeKicAzrdMVfLrXF5z1Mp3k8qQ4SeNFIaEzfZ_uE130_provenance.
- NP1104471.RAA7sN1wXm2NuGko1bOjInAcRJmZnmyL6XL5NMiv3ARjo130_assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1104471.RAA7sN1wXm2NuGko1bOjInAcRJmZnmyL6XL5NMiv3ARjo130_provenance.
- NP423536.RA90s90V3IdRDFDUXD2b7zfSabxefPV860w7YMe_SU5KI130_assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP423536.RA90s90V3IdRDFDUXD2b7zfSabxefPV860w7YMe_SU5KI130_provenance.
- NP423567.RAyt_EgWSXd1lbfQ3Aho6BPcAKeOgPmPU6NiDA-JWmry0130_assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP423567.RAyt_EgWSXd1lbfQ3Aho6BPcAKeOgPmPU6NiDA-JWmry0130_provenance.
- NP470254.RAUiq_KboEBRMWTZ1wABG782Nc349jwGDZJG5B38dHPIQ130_assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP470254.RAUiq_KboEBRMWTZ1wABG782Nc349jwGDZJG5B38dHPIQ130_provenance.
- NP470343.RAVKJYxaB0iwHRuhUEJlQ4yu6-aytP6ybEeApUJxBxZBs130_assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP470343.RAVKJYxaB0iwHRuhUEJlQ4yu6-aytP6ybEeApUJxBxZBs130_provenance.
- NP470578.RARUq-ZwKYqGIl4fr6wRE_nKEqSdQ6bpS2SSUwpMJk4eo130_assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP470578.RARUq-ZwKYqGIl4fr6wRE_nKEqSdQ6bpS2SSUwpMJk4eo130_provenance.
- assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1104480.RAyf4drAS0bzlx93bJWaPCFsdcRwbJuIdylGL6wv47A1o130_assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1104480.RAyf4drAS0bzlx93bJWaPCFsdcRwbJuIdylGL6wv47A1o130_provenance.
- NP423628.RAHEue26ejiLxGPs2ClRp7dv081gFM9nF8NOkalQi2AF8130_assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP423628.RAHEue26ejiLxGPs2ClRp7dv081gFM9nF8NOkalQi2AF8130_provenance.
- NP423644.RAL65hB4UClnOqaT28pdTM858TnA7I25qNf9H0NRrcyAg130_assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP423644.RAL65hB4UClnOqaT28pdTM858TnA7I25qNf9H0NRrcyAg130_provenance.
- NP470662.RAjp8niBl9jCuA3_RihBokoXUwG2QNyFtfhNAkiBigUBs130_assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP470662.RAjp8niBl9jCuA3_RihBokoXUwG2QNyFtfhNAkiBigUBs130_provenance.
- NP1104474.RAG5Moo2An6elVyrHIJQh0AjQfQNA8lFzPD_G0O3m5cHc130_assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1104474.RAG5Moo2An6elVyrHIJQh0AjQfQNA8lFzPD_G0O3m5cHc130_provenance.
- NP1104477.RAIXWPfgjlOA-FTDsWpieW3Wm72sxNdKMr60n6JMmHD2c130_assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1104477.RAIXWPfgjlOA-FTDsWpieW3Wm72sxNdKMr60n6JMmHD2c130_provenance.
- NP1104473.RAl9e-M0Z_7J0PF3EgTFfadlEsfwowrsjJO_UyRgnW7IY130_assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1104473.RAl9e-M0Z_7J0PF3EgTFfadlEsfwowrsjJO_UyRgnW7IY130_provenance.
- NP1104476.RAm6lfz8IT_a3uNcDgFBJlG6wgyjeN-lDqjfLhRbIwcDQ130_assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1104476.RAm6lfz8IT_a3uNcDgFBJlG6wgyjeN-lDqjfLhRbIwcDQ130_provenance.
- NP1104479.RAsMadbgsk_9IWaDumURV5oyAkXX2bRnwh8OSHibEMT_k130_assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1104479.RAsMadbgsk_9IWaDumURV5oyAkXX2bRnwh8OSHibEMT_k130_provenance.
- NP1104481.RArpGGzo5tDPqecLKew1Wt65a5CaVrkPfVmEHCXOLRjfI130_assertion description "[To evaluate the role of whole genome comparative genomic hybridisation microarray (array-CGH) in detecting genomic imbalances as compared to conventional karyotype (GTG-analysis) or myeloma specific fluorescence in situ hybridisation (FISH) panel in a diagnostic setting for plasma cell dyscrasia (PCD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1104481.RArpGGzo5tDPqecLKew1Wt65a5CaVrkPfVmEHCXOLRjfI130_provenance.